Gaithersburg, MD, United States of America

Jia Zhou

This inventor holds 1 USPTO granted patent. Top assignees: Sirnaomics Medicine Technology (Suzhou) Co, Ltd., Sirnaomics, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jia Zhou. Retrieved from https://idiyas.com/inventor/jia-zhou-quogcbg6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Jia Zhou

Introduction

Jia Zhou is an accomplished inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of pharmaceuticals, particularly in the area of fibroblast and myofibroblast apoptosis. Her innovative work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Jia Zhou holds a patent for "Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis." This invention provides a method for activating fibroblast and myofibroblast apoptosis in mammalian tissue. The method involves administering a therapeutically effective amount of a composition that includes siRNA molecules targeting TGFB1 and COX-2 proteins, along with a pharmaceutically acceptable carrier.

Career Highlights

Throughout her career, Jia Zhou has worked with notable companies such as Sirnaomics, Inc. and Sirnaomics Medicine Technology (Suzhou) Co., Ltd. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the pharmaceutical sector.

Collaborations

Jia Zhou has collaborated with esteemed colleagues, including John Xu and Patrick Y Lu. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Jia Zhou is a pioneering inventor whose work in pharmaceutical compositions has the potential to transform therapeutic practices. Her dedication to innovation continues to inspire advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…